At-home, handheld telehealth device
This article was originally published in Start Up
TytoCare Ltd.'s Tyto is a telehealth platform and a handheld device with various snap-on attachments to be purchased over the counter to conduct a comprehensive set of physical examinations in the convenience and comfort of one’s own home. The cloud platform allows consumers to perform a self-examination and transmit diagnostic readings to a primary-care physician, as well as conduct an online visit with a remote physician who can also control the device while teleconferencing with the patient.
You may also be interested in...
The latest accelerated approval withdrawals in the US are milestones for accountability in the program – most notably with the withdrawal of an antimicrobial with confirmatory studies more than a decade overdue.
Based on promising Phase II data, two companies in South Korea are moving ahead with late-stage development in the gout space, with JW Pharmaceutical getting approvals to begin a multinational Phase III trial for epaminurad, while LG Chem has recently submitted an application for a Phase III program with its contender tigulixostat.
Final guidance targets the ‘multiplicity problem.’ At about half the length of the 2017 draft, the final removes some sections, truncates other and drops several examples.